Leerink Partners analyst Mike Kratky maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) on November 25 and set a price ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now discontinuing its patch pump program as part of a broader restructuring ...

Tandem's sales growth has failed to translate to shareholder wealth for several reasons. Click here to read why TNDM stock is ...

The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous ...

The variables assessed included glycemic control (glycohemoglobin and blood glucose), total insulin dose, and body weight. Because the interaction effect of these covariates with time (pre- vs.

Other companies are looking to administer insulin with needle-free devices, and insulin pumps, which also make therapy more convenient, are already gaining in popularity. Novo Nordisk is investing ...

After hours: November 22 at 6:27 PM EST Loading Chart for TNDM ...